Home Tools

Vadimezan

Catalog No. T6273 CAS 117570-53-3

Synonyms: DMXAA, 5,6-Dimethylxanthenone-4-acetic Acid, NSC 640488, ASA-404

Vadimezan (DMXAA) is a vascular disrupting agent, a murine STING agonist, and an inducer of cytokines such as type I IFN. Vadimezan has antitumor activity and induces a rapid cessation of blood flow in tumors without affecting blood flow in normal tissues.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Vadimezan, CAS 117570-53-3

Pack Size	Availability	Price/USD
2 mg	In stock	$ 48.00
5 mg	In stock	$ 81.00
10 mg	In stock	$ 110.00
25 mg	In stock	$ 239.00
50 mg	In stock	$ 432.00
100 mg	In stock	$ 475.00
1 mL * 10 mM (in DMSO)	In stock	$ 90.00

Bulk Inquiry

Select Batch

Purity: 99.8%

Purity: 99.36%

Purity: 98.5%

Purity: 97.81%

Purity: 97.38%

Biological Description

Chemical Properties

Storage & Solubility Information

Description	Vadimezan (DMXAA) is a vascular disrupting agent, a murine STING agonist, and an inducer of cytokines such as type I IFN. Vadimezan has antitumor activity and induces a rapid cessation of blood flow in tumors without affecting blood flow in normal tissues.
Targets&IC50	DT diaphorase:20 μM(Ki)
In vitro	METHODS: DLBCL cells LY1 and LY3 were treated with Vadimezan (0-300 µM) for 24 h. Cell viability was measured by CCK-8 assay. RESULTS: Vadimezan treatment decreased the viability of DLBCL cells in a dose-dependent manner, with IC50s of 177 μM and 165 μM for LY1 and LY3, respectively. [1] METHODS: Human lung cancer cells A549 were treated with Vadimezan (0.1-1 µM) for 24 h. The expression levels of target proteins were detected by Western Blot. RESULTS: Vadimezan induced a significant increase in the cytoplasmic level of cytochrome c and the activation of caspase 3, which ultimately led to apoptosis and death of A549 cells. [2]
In vivo	METHODS: To assay antitumor activity in vivo, Vadimezan (20 mg/kg) and BMS1166 (250 µg/mL) were injected intraperitoneally into Balb/c nude mice bearing DLBCL tumor LY1 once daily for eight days. RESULTS: Vadimezan and BMS1166 acted at effective concentrations. The combination treatment significantly inhibited the growth of GCB-like DLBCL cells compared to monotherapy. [1] METHODS: To assay antitumor activity in vivo, Vadimezan (25,5,5,25 mg/kg; 25,0,0,25 mg/kg; 25,25,25,25 mg/kg) was administered intraperitoneally every three days to C57BL/6J mice bearing mouse mesothelioma AE17 for four doses. RESULTS: In group 1, 2/4 mice were cured, of which 2/4 showed long-term survival, but toxicity problems were observed. A better, less toxic response was observed in Group 2, with all four mice cured and showing long-term survival. In group 3, only 1 mouse was cured, but none showed long-term survival, possibly due to associated toxicity issues. [3]
Kinase Assay	DT-diaphorase activity and kinetic analysis of enzyme inhibition : Purified DT-diaphorase enzyme activity is assayed by measuring the reduction of cytochrome c at 550 nm on a Beckman DU 650 spectrophotometer. Each assay contains cytochrome c (70 μM), NADH (variable concentrations), purified DT-diaphorase (0.032 μg), and menadione (variable concentrations) in a final volume of 1 mL Tris–HCl buffer (50 mM, pH 7.4) containing 0.14% BSA. The reaction is started by the addition of NADH. Rates of reduction are calculated over the initial part of the reaction curve (30 seconds), and results are expressed in terms of μmol cytochrome c reduced/min/mg protein using a molar extinction coefficient of 21.1 mM?1 cm?1 for reduced cytochrome c. Enzyme assays are carried out at room temperature and all reactions are performed in triplicate. Inhibition of purified DT-diaphorase activity is performed by the inclusion of DMXAA (at various concentrations) in the reaction, and inhibition characteristics are determined by varying the concentration of NADH (constant menadione) or menadione (constant NADH) at several concentrations of inhibitor. Ki values are obtained by plotting 1/V against. The activity of DT-diaphorase in DLD-1 cells is determined by measuring the dicumarol-sensitive reduction of DCPIP at 600 nm. Briefly, DLD-1 cells in mid-exponential growth are harvested by scraping into ice-cold buffer (Tris–HCl, 25 mM, pH 7.4 and 250 mM sucrose) and sonicated on ice. Enzyme assay conditions are 2 mM NADH, 40 μM DCPIP, 20 μL of dicumarol (when required) in a final volume of 1 mL Tris–HCl (25 mM, pH 7.4) containing BSA (0.7 mg/mL). Results are expressed as the dicumarol-sensitive reduction of DCPIP using a molar extinction coefficient of 21 mM?1 cm?1. Protein levels are determined using the Bradford assay
Cell Research	DLD-1 human colon carcinoma and H460 human non-small cell lung carcinoma cells are routinely maintained as monolayer cultures in RPMI 1640 culture medium supplemented with foetal calf serum (10%), sodium pyruvate (2 mM), penicillin/streptomycin (50 IU mL?1/50 μg mL-1) and l-glutamine (2 mM). Chemosensitivity is assessed using the MTT assay and all assays are performed under aerobic conditions. Briefly, cells are plated into each well of a 96-well culture plate and incubated overnight in an atmosphere containing 5% CO2. Culture medium is completely removed from each well and replaced with medium containing a range of drug concentrations. In the case of menadione alone, the duration of drug exposure is 1 hour, after which the cells are washed twice with Hanks' balanced salt solution prior to the addition of 200 μL fresh RPMI 1640 medium to each well of the plate. In the case of DMXAA alone, the duration of drug exposure is 3 hours. Following a four-day incubation, cell survival is determined using the MTT assay. For combinations of DMXAA with menadione, cells are initially set up and a non-toxic (>95% cell survival) concentration of DMXAA is selected. Cells are then initially exposed to DMXAA (2 mM) for a period of 2 hours, following which the medium is removed and replaced with medium containing the inhibitor (DMXAA at a constant concentration of 2 mM) and menadione (at a range of drug concentrations). Following a further 7-hour incubation, cells are washed twice with Hanks' balanced salt solution prior to the addition of growth medium.(Only for Reference)

Synonyms	DMXAA, 5,6-Dimethylxanthenone-4-acetic Acid, NSC 640488, ASA-404
Molecular Weight	282.29
Formula	C17H14O4
CAS No.	117570-53-3

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 5.7 mg/mL (20 mM)

References and Literature

1. Cai Y, et al. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma. Int J Biol Sci. 2023 Aug 28;19(14):4627-4643. 2. Pan ST, et al. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach. Drug Des Devel Ther. 2015 Feb 17;9:937-68. 3. Graham PT, et al. The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model. Front Immunol. 2022 Nov 18;13:969678. 4. Liu JJ, et al. Cancer Chemother Pharmacol. 2007, 59(5), 661-669. 5. Chen C, Yan W, Zhang Y, et al. ANP Attenuates Intestinal Inflammation by Regulating STING Pathway[J]. Available at SSRN 3756807. 6. Zhao M, Wang B, Zhang C, et al. The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease[J]. Cell Death & Differentiation. 2021: 1-19.

Citations

1. Zhao M, Wang B, Zhang C, et al. The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease. Cell Death & Differentiation. 2021: 1-19. 2. Chen C, Zhang Y, Tao M, et al. Atrial Natriuretic Peptide Attenuates Colitis via Inhibition of the cGAS-STING Pathway in Colonic Epithelial Cells. International Journal of Biological Sciences. 2022, 18(4): 1737-1754.

Related compound libraries

This product is contained In the following compound libraries：

Drug Repurposing Compound Library Anti-Cancer Clinical Compound Library Anti-Cancer Active Compound Library Anti-Cancer Drug Library Anti-Prostate Cancer Compound Library Anti-Infection Compound Library Target-Focused Phenotypic Screening Library Immunology/Inflammation Compound Library Apoptosis Compound Library Anti-Viral Compound Library

Related Products

Related compounds with same targets

Tubercidin Octyl gallate CEF3 acetate(199727-62-3 free base) Dehydroandrographolide Platyphyllonol Hyperoside 3,4-Dicaffeoylquinic acid Clemastanin B

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Vadimezan 117570-53-3 Angiogenesis Immunology/Inflammation Microbiology/Virology VDA Influenza Virus STING IFNAR Interferon-α/β receptor DMXAA Stimulator of Interferon Genes MITA TMEM173 inhibit 5,6-Dimethylxanthenone-4-acetic Acid Inhibitor NSC 640488 NSC-640488 MPYS ERIS ASA 404 ASA404 NSC640488 Interferon-alpha/beta receptor ASA-404 inhibitor

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.